ReviewFrontiers in oncology2023

Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice.

Ignacio Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.